Marcos Milla
Venture Partner at Samsara BioCapital
Carlsbad, California
Overview
Work Experience
Member
2023 - Current
Universidad Peruana Cayetano Heredia is a top institution in Latin America for education and research in biomedical sciences. We are boosting institutional development through its Board of Patrons (Patronato)
Venture Partner
2021
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.
President
2020
The Milla Goni Family Foundation creatively curates and provides access to capital, research, and connections to Peruvian change-makers from marginalized communities to launch mutualist, restorative solutions in healthcare, food + water justice, equitable labor + income, and decolonized education: https://themillagonifoundation.org/
Chief Scientific Officer
2018 - 2021
Senior Vice President of Research
2017 - 2018
Synthorx is a biotechnology company using synthetic biology to synthesize solutions.
Raised $76,125,000.00 from Correlation Ventures, RA Capital Management, OUP (Osage University Partners), Avalon Ventures, Medicxi and OrbiMed.
Vice President, Therapeutics
2016 - 2017
Adaptive Biotechnologies translates scale and precision of the adaptive immune system into products to diagnose and treat disease.
Raised $531,850,000.00 from OrbiMed.
Global Head, Emerging Science & Innovation, Discovery Sciences
2014 - 2016
Scientific Director and Fellow, Immunology Discovery
2009 - 2014
Team Leader - Exploratory Platforms
Director
2005 - 2009
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on
Professor
1998 - 2005
Research on the structure and function of the TNF-alpha converting enzyme (TACE)
Research Investigator
1995 - 1998
Post Doctoral Fellow
1990 - 1993